.AstraZeneca has shared a very early take a look at the efficiency of its internal antibody-drug con...
.After revealing a phase 3 launch based upon positive midstage outcomes, iTeos and also GSK are ulti...
.The FDA should be extra open as well as joint to discharge a rise in approvals of unusual condition...
.It's an extraordinarily active Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Rehabs...
.Atea Pharmaceuticals' antiviral has neglected yet another COVID-19 trial, yet the biotech still kee...
.Neurocrine Biosciences' schizophrenia course pivot has stopped working. The biotech was unable to d...
.Sanofi has actually made an overdue entry to the radioligand gathering, spending 100 thousand euros...
.After F2G's 1st effort to receive a new training class of antifungal to market was derailed by the ...
.Moderna has promised to reduce R&D spending by $1.1 billion by 2027. The decision to shrink the ...
.Just four months after Sanofi wager $80 million in beforehand cash money on Key Rehabs' losmapimod,...